| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5698178 | Clinical Oncology | 2014 | 7 Pages |
Abstract
These results suggest that cervical cancer patients treated with radiotherapy and concurrent cisplatin do not benefit from elective PART.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
M.L. Yap, J. Cuartero, J. Yan, M. Pintilie, A. Fyles, W. Levin, L. Manchul, M. Milosevic,